A detailed history of Engineers Gate Manager LP transactions in Replimune Group, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 22,680 shares of REPL stock, worth $288,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,680
Holding current value
$288,036
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.01 - $9.46 $113,626 - $214,552
22,680 New
22,680 $204,000
Q3 2023

Nov 14, 2023

BUY
$15.96 - $22.18 $56,067 - $77,918
3,513 Added 23.59%
18,402 $314,000
Q2 2023

Aug 14, 2023

BUY
$15.65 - $24.1 $233,012 - $358,824
14,889 New
14,889 $345,000
Q3 2022

Nov 14, 2022

SELL
$15.6 - $21.15 $57,782 - $78,339
-3,704 Reduced 25.96%
10,566 $182,000
Q2 2022

Aug 15, 2022

SELL
$13.32 - $19.98 $150,222 - $225,334
-11,278 Reduced 44.14%
14,270 $249,000
Q1 2022

May 16, 2022

BUY
$15.24 - $29.75 $389,351 - $760,053
25,548 New
25,548 $434,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $626M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.